SecBot SecBot

RVMD

Revolution Medicines, Inc.
Nasdaq· Biological Products, (No Diagnostic Substances)· Inc. DE· CIK 0001628171 Biotech & Drug Discovery
$166.87 −5.42 (−3.15%)
Nov 16 4:00 PM ET · prev $172.29
Market cap
$38.1B
Large cap
Consensus
Buy
94% Buy or better · 31 analysts
Median target
$272.00
+63% · range $179.00–350.00
1 year
+141.4%
from $69.14 · Nov 17
30 days
−8.4%
from $182.15
52-week range
$69.14–221.15
−25% from high · low Nov 17
Avg volume 20D
2.39M
Nov 5 spike 7.81M
Short interest
13.08M
≈6.0% of shares · +1.1%
Days to cover
7.8
at average volume
Insider net
−$18.6M
0 buyers · 8 sellers · since Sep 16
New fund stakes
2
Q3 2026 13F · 3 exits
Filing reports
33
analyzed by SecBot
SecBot read BULLISH 25 reports · 90 days
Balance 3 bearish · 6 bullish · 16 neutral oldest → newest, height = score
Avg score ·High conf. 14/25

Price

Daily candles with volume. Callouts mark insider and congressional trades, rating changes, 13F stakes, reports, catalysts, court and regulator actions, Reddit spikes and short-interest jumps. Hover one for the details (tap on phones).

Signal stack

Where each data set points today.

  • InsidersBEARISH

    8 insiders sold $18.6M.

  • InstitutionsBULLISH

    Q3 2026: 75 added (2 new), 22 trimmed or exited. Largest new: Winslow Capital Management $260.2M.

  • AnalystsBULLISH

    29 of 31 rate it Buy or better. Every target is above the price.

  • Short sellersSTEADY

    Short interest +1.1% to 13.08M shares. 7.8 days to cover, ≈6.0% of shares.

  • TrendDOWNTREND

    14% below its 50-day average.

  • SocialQUIET

    No Reddit mentions this week. Last mention Nov 7.

Who's buying

13F· Q3 2026
2
new positions
3
exits
$260.2M
in new stakes · top 1 shown
FundMoveSharesValue
FMR LLCADD15,397,714$3.2B
Capital World InvestorsADD5,458,162$1.1B
JPMORGAN CHASE & COADD4,747,380$973.1M
Assenagon Asset Management S.A.DOUBLED2,181,185$447.7M
FRANKLIN TEMPLETON INCADD1,957,064$390.8M
Winslow Capital Management, LLCNEW1,267,618$260.2M
DEUTSCHE BANK AG\ADD1,144,679$235.0M
Invesco Ltd.ADD861,628$176.9M

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

31 analysts
Buy 94% rate it Buy or better
Strong Buy12Buy17Hold2Sell0Strong Sell0
12-month targets · 24 analysts

Price is below the lowest target. Median implies +63%.Targets as of Nov 17, 2026.

Recent actions
DateFirmActionRating
Nov 13, 2026Morgan Stanley
MAINTAIN
MAINTAINOverweight
Nov 6, 2026HC Wainwright & Co.
MAINTAIN
MAINTAINBuy
Nov 5, 2026TD Cowen
MAINTAIN
MAINTAINBuy
Nov 5, 2026RBC Capital
MAINTAIN
MAINTAINOutperform
Nov 5, 2026Piper Sandler
MAINTAIN
MAINTAINOverweight
Nov 5, 2026Truist Securities
REITERATE
REITERATEBuy

Insider ledger

Form 4
$0
bought · 0 insiders
$18.6M
sold · 8 insiders
DateInsiderTypeValue
Nov 11, 2026
Borisy Alexis
Director
Nov 11, 2026
GIFT10,625 sh
Nov 11, 2026
Anders Jack
Chief Financial Officer
Nov 11, 2026
SELL$37.8K
Nov 11, 2026
Anders Jack
Chief Financial Officer
Nov 11, 2026
EXERCISE$675.0K
Nov 11, 2026
Anders Jack
Chief Financial Officer
Nov 11, 2026
SELL$633.5K
Nov 11, 2026
Anders Jack
Chief Financial Officer
Nov 11, 2026
SELL$74.6K
Nov 11, 2026
Anders Jack
Chief Financial Officer
Nov 11, 2026
EXERCISE$368.4K
Nov 11, 2026
Anders Jack
Chief Financial Officer
Nov 11, 2026
SELL$1.1M
Nov 11, 2026
Anders Jack
Chief Financial Officer
Nov 11, 2026
SELL$493.8K

Earnings setup

Estimates

Revision history: 🔒 Fresh data, subscribers only

PeriodEPS est.Range30D rev.Revenue
Current Q🔒 Fresh data, subscribers only
Next Q-$0.81-$2.35–$0.38+55.9%$462.0M
Current FY🔒 Fresh data, subscribers only
Next FY🔒 Fresh data, subscribers only
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
2 drugs tracked · Drug pipeline →
Recent

Short side

FINRA· Oct 30, 2026
13,078,963
shares short
+1.1%
vs prior settlement
7.8
days to cover
≈6.0%
of shares outstanding
Recent activity
The latest filings, insider trades, analyst actions, press and options flow, newest first.
Nov 16, 2026 SEC
🔒 Fresh report (last 24h), subscribers only
Nov 16, 2026 Other
🔒 Fresh data, subscribers only
Nov 16, 2026 SEC
🔒 Fresh report (last 24h), subscribers only
Nov 13, 2026 SEC
Two insiders at Revolution Medicines sold shares in the week following Q3 earnings that showed RASONQUE revenue far…
CLUSTER · Impact 2/10
Nov 11, 2026 Insider
Borisy Alexis gifted 10,625 shares
Director
Nov 11, 2026 Insider
Anders Jack sold 200 shares
Chief Financial Officer @ $189.17 ($37.8K)
Nov 11, 2026 Insider
Anders Jack acquired via exercise 15,900 shares
Chief Financial Officer @ $42.45 ($675.0K)
Sep 30, 2026 Inst.
FMR LLC · ADD
15,397,714 shares ($3.2B)
Reddit Mentions per day, 14 days
Recent posts
All social signals and their track records

SecBot reports

33 filings · 11 press releases · 5 bullish · 3 bearish · 25 neutral
All RVMD filing & press-release reports (44)